Rockwell Medical (RMTI) Revenue (2010 - 2026)

Rockwell Medical (RMTI) has reported Revenue for 17 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 10.63% year-over-year to $17.8 million; the trailing twelve-month figure through Jun 2026 stood at $69.4 million (down 21.12% YoY), and the FY2025 full-year result was $69.3 million, down 31.76% from the prior year.
• Revenue grew to $17.8 million in Q2 2026 per RMTI's latest filing, from $17.3 million in the prior quarter.
• Across five years, Revenue topped out at $28.3 million in Q3 2024 and bottomed at $15.9 million in Q3 2025.
• Historically, Revenue has averaged $20.1 million across 5 years, with a median of $18.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Revenue jumped 42.88% in 2024, then sank 43.75% in 2025.
• Over 5 years, Revenue stood at $19.3 million in 2022, then increased by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then slipped by 25.62% to $18.3 million in 2025, then declined by 3.09% to $17.8 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $17.8 million, $17.3 million, and $18.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.